To further clarify the distinct enzymatic role of CD73 in mediating lung adenocarcinoma (LUAD) and LUSC, we first examined the expression levels of CD73, Axl, and A2AR in NSCLC cell lines. The gene discussed is AXL; the disease is non-small cell lung carcinoma.